Ospedale "A. Perrino" — Clinical Trial Site

8 Registered trials

4 Currently recruiting

Organisation

Ospedale "A. Perrino"

Location

Brindisi, Italy

Identifier

ORL-000002456

Address

Strada Statale 7 (APPIA), 72100, Italy

Departments

Burn center
General Surgery
Oncologia Medica
Oncologia Medica - Ospedale Senatore Antonio Perrino, Brindisi (BR)
U.O. Oncologia Medica
U.O.C. Oncologia Medica
UOC Oncologia Medica

Clinical trials at this site (8)

Search interface

MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, … Recruiting

2024-516839-27-00 BRCA wild-type advanced ovarian, fallopian tube and pri 4 2024-12-09
Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting

2024-518534-81-00 metastatic colorectal cancer 4 2021-07-01
Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-sm… Recruiting

2024-517200-10-00 Advanced non-small-cell lung cancer 4 2020-01-31
Palbociclib plus fulvestrant in women with hormone receptor positive and human epidermal growth factor receptor type 2 negative locally adva… Recruiting

2024-513372-18-00 Pre- and post-menopausal women with HR+/HER2- LABC or M 4 2019-10-18
BEVERLY: A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with… Ended

2024-516843-15-00 Non-squamous Non-small Cell Lung Cancer 5 2015-11-23
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended

2024-512848-30-00 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER 4 2024-11-12
VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial Ended

2023-504772-21-00 Severely burned patients 4 2022-11-22
Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlle… Ended

2025-520735-16-00 CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX 4